Wednesday, July 8, 2026
ADVT 
National

Saudi blogger spared flogging again this week: Amnesty International

Darpan News Desk The Canadian Press, 13 Feb, 2015 10:46 AM

    MONTREAL — Saudi Arabia postponed a planned flogging of blogger Raif Badawi for a fifth consecutive week, Amnesty International said Friday.

    The human rights watchdog said through Twitter that Badawi was spared lashes for unknown reasons.

    Badawi is serving 10 years in prison and has also been sentenced to 1,000 lashes for blog posts criticizing Saudi Arabia's clerics.

    The first 50 lashes were delivered on Jan. 9 and Amnesty said none have taken place since then. Some were postponed for medical reasons.

    Badawi was arrested in 2012, the same year his wife and children fled Saudi Arabia, settling in Sherbrooke, Que., in 2013.

    Badawi was originally sentenced in 2013 to seven years in prison and 600 lashes, but an appeals judge stiffened the punishment and fined him one million Saudi riyals, or more than $300,000.

    His detention and sentence have stirred up worldwide condemnation.

    European Union lawmakers passed a resolution on Thursday demanding Badawi's immediate release and condemning the flogging as a "cruel and shocking act."

    In Quebec, the provincial legislature passed a similar motion Wednesday with Badawi's wife, Ensaf Haidar, in attendance.

    Prime Minister Stephen Harper also spoke out against Badawi's treatment during a Quebec announcement on Thursday.

    He said that Canada's influence is limited by the fact that Badawi is not a citizen, but the country would continue to defend fundamental freedoms.

    "We find the gestures imposed on Mr. Badawi to be barbaric, and we will continue to express our views," Harper said.

    MORE National ARTICLES

    Tekmira in talks about using experimental Ebola drug in infected patients

    Tekmira in talks about using experimental Ebola drug in infected patients
    VANCOUVER - Tekmira Pharmaceuticals Corp. (TSX:TKM) is in discussions about making its experimental Ebola drug available to infected patients, but says there is no guarantee the treatment can be used to help quell the outbreak in West Africa.

    Tekmira in talks about using experimental Ebola drug in infected patients

    Vancouver police officer used too much force during traffic stop: watchdog

    Vancouver police officer used too much force during traffic stop: watchdog
    A Vancouver police officer used excessive and unnecessary force when he punched a driver three times during a traffic stop in 2012, said a ruling by B.C.'s police watchdog.

    Vancouver police officer used too much force during traffic stop: watchdog

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto
    A Calgary company is looking to boost the profile of the world's newest, and most controversial, currency with the launch of six more teller machines in Toronto that deal in the virtual currency Bitcoin.

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    White House talking to Canada, others about aiding Iraqi refugees

    White House talking to Canada, others about aiding Iraqi refugees
    The United States is considering a multinational mission to whisk displaced people to safety in Iraq and it appears there may be a supporting role for Canada.

    White House talking to Canada, others about aiding Iraqi refugees

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful
    A special prosecutor has approved polygamy charges against the two leaders of an isolated religious sect in southeastern British Columbia.

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    Ebola drug developer Tekmira's net loss widens during second quarter

    Ebola drug developer Tekmira's net loss widens during second quarter
    Tekmira Pharmaceuticals Corp. (TSX:TKM) says it's in talks with governments and non-governmental organizations in various countries about the potential use of its experimental Ebola drug in infected patients.

    Ebola drug developer Tekmira's net loss widens during second quarter